Primer for detection and quantification of pathogenic and non-pathogenic newcastle disease virus using rrt-pcr and use thereof

MYPI2025004658A0Undetermined Publication Date: 2024-08-13REPUBLIC OF KOREA (ANIMAL AND PLANT QUARANTINE AGENCY)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025004658
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-02-13
Filing Date
2024-02-05
Publication Date
2024-08-13

AI Technical Summary

Technical Problem

Current methods for detecting and differentiating Newcastle disease virus (NDV) and its pathogenic forms are time-consuming, require skilled manpower and expensive equipment, and have limitations in detecting emerging virulent strains, particularly intermediate and highly virulent types.

Method used

Development of a multiplex real-time reverse transcription PCR (rRT-PCR) method using specific primer sets that can simultaneously detect and quantify NDV, distinguishing between pathogenic and non-pathogenic strains with high sensitivity and specificity, employing combinations of NDV common and pathogenic-specific primer sets with labeled probes for accurate nucleic acid amplification.

Benefits of technology

Enables rapid and accurate detection and differentiation of NDV and its pathogenic forms, reducing the time and resources required for diagnosis, and facilitating effective disease monitoring and vaccine development.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure PI2025004658_DRAWING_001
    Figure PI2025004658_DRAWING_001
  • Figure PI2025004658_DRAWING_002
    Figure PI2025004658_DRAWING_002
  • Figure PI2025004658_DRAWING_003
    Figure PI2025004658_DRAWING_003
Patent Text Reader

Abstract

The present application discloses a combination of primer sets capable of simultaneously detecting both pathogenic and non-pathogenic Newcastle Disease Virus (NDV), including mesogenic and velogenic strains. The primer sets and combinations according to the present application not only enable the rapid detection of NDV contamination with high specificity and sensitivity in various samples, including pathological examination samples in the veterinary field, but also are useful for distinguishing between NDV and pathogenic (mesogenic and velogenic) NDV and for titration, thus finding wide applications in disease monitoring in poultry farms.
Need to check novelty before this filing date? Find Prior Art

Description

Primers and their uses for detection and quantification of pathogenic and nonpathogenic Newcastle disease viruses using RRT-PCR.

[0001] The present invention relates to primers and their uses that can simultaneously and accurately and rapidly detect and differentiate Newcastle disease virus and pathogenic (intermediate virulent and virulent) Newcastle disease virus using a multiplex RT-PCR method, and can also be used for quantification of Newcastle disease virus.

[0002] Newcastle disease (ND) is caused by the Newcastle disease virus (NDV). It is highly contagious and has a high mortality rate. Therefore, according to the Newcastle disease prevention guidelines, any suspected chickens, like highly pathogenic influenza, must be reported promptly. Farms where Newcastle disease is confirmed to have occurred will be culled. In particular, since ND is designated as a reportable disease by the World Organization for Animal Health (WOAH), imports and exports are restricted in the event of an outbreak, which can cause significant economic damage to the poultry industry.

[0003] NDV belongs to the genus Avulavirus in the family Paramyxoviridae and can infect most birds, including chickens, pheasants, ostriches, pigeons, quail, turkeys, and geese. NDV is classified into velogenic, mesogenic, lentogenic, and apathogenic types depending on the virulence of the virus. In the WOAH, infection by NDV with mesogenic or higher virulence types is considered Newcastle disease, and infection causes respiratory, digestive, and neurological symptoms. When infected with the mesogenic type, weight loss or reduced egg production occurs, and death may occur in young chicks. When infected with the highly virulent type, green diarrhea and reduced egg production along with neurological symptoms can occur, and the mortality rate can be almost 100%. Furthermore, even if immunity is acquired through vaccination, death can occur in up to 50% of chickens when infected with the highly virulent type. Therefore, in poultry farms, when a suspected case occurs, it is important to quickly and accurately diagnose NDV showing pathogenicity (intermediate and highly virulent types) and take early quarantine measures.

[0004] Traditionally, when a suspected case occurred, NDV was isolated from poultry sample specimens, and the pathogenicity of the isolated NDV was confirmed by measuring the mean death time (MDT) in 9-10-day-old SPF (specific pathogen free) embryonic eggs, the intracerebral pathogenicity index (ICPI) in 1-day-old chicks, or the intravenous pathogenicity index (ICPI) in 6-week-old SPF chickens, and then Newcastle disease was diagnosed. However, this method is time-consuming and requires skilled personnel and expensive equipment because it uses eggs and animals, so gene amplification methods such as PCR (RT-PCR or reverse real-time PCR) are widely used. Some of the existing known genetic amplification methods were designed to detect only intermediate-virulence or higher pathogenic NDVs (intermediate-virulence and highly virulent) using the segmented region of the F protein. However, new pathogenic NDVs (intermediate-virulence and highly virulent) are emerging in China and Southeast Asia, where there is a possibility of domestic introduction, and there are limitations in not detecting some NDVs (Kim et al., 2017, Du et al., 2020).

[0005] Therefore, it is necessary to develop a polymerase chain reaction method that can detect and differentiate NDV and pathogenic (intermediate and highly virulent) NDV infections early with high specificity, sensitivity, and reliability, and simultaneously measure the titer of NDV rapidly and accurately.

[0006] The present invention aims to provide a method for rapidly and easily detecting and simultaneously measuring the titer of non-pathogenic Newcastle disease virus and pathogenic (intermediate and highly virulent) Newcastle disease virus, while exhibiting high sensitivity and specificity.

[0007] In one aspect, the present invention provides a combination of NDV common and pathogenic NDV-specific primer sets for rRT (real-time reverse transcription)-PCR (Polymerase Chain Reaction) analysis for simultaneous detection of pathogenic and non-pathogenic NDV (Newcastle Disease Virus) in poultry, wherein the NDV common primer set is: a first primer set of SEQ ID NO: 1 and SEQ ID NO: 2; a second primer set of SEQ ID NO: 4 and SEQ ID NO: 5; a third primer set of SEQ ID NO: 7 and SEQ ID NO: 8; or a fourth primer set of SEQ ID NO: 10 and SEQ ID NO: 11; and wherein the pathogenic NDV-specific primer set is: a fifth primer set of SEQ ID NO: 13 and SEQ ID NO: 14; a sixth primer set of SEQ ID NO: 13 and SEQ ID NO: 16; or a seventh primer set of SEQ ID NO: 13 and SEQ ID NO: 17, and the combination of primer sets for simultaneous detection comprises: the first primer set and the fifth primer set; Any one combination selected from the group consisting of combinations of the first primer set and the sixth primer set; the first primer set and the seventh primer set; the second primer set and the fifth primer set; the second primer set and the sixth primer set; the second primer set and the seventh primer set; the third primer set and the fifth primer set; the third primer set and the sixth primer set; the third primer set and the seventh primer set; the fourth primer set and the fifth primer set; the fourth primer set and the sixth primer set; and the fourth primer set and the seventh primer set.

[0008] In one embodiment, each of the primer sets is used with a probe, wherein the first primer set, the second primer set, the third primer set and the fourth primer set are used with probes of SEQ ID NO: 3, SEQ ID NO: 6, SEQ ID NO: 9 and SEQ ID NO: 12, respectively, and the fifth primer set, the sixth primer set and the seventh primer set are used with probes of SEQ ID NO: 15 or SEQ ID NO: 18, respectively, wherein each probe is labeled with a detectable label.

[0009] In one embodiment, each probe used with the common and pathogen-specific primer sets is labeled with a fluorescent substance of a different wavelength.

[0010] In another aspect, the present invention provides a composition or kit for rRT-PCR analysis for simultaneous detection of pathogenic and non-pathogenic NDV in poultry, comprising a combination of NDV common and pathogenic NDV specific primer sets for rRT-PCR analysis according to the present invention.

[0011] In one embodiment, the composition and kit further comprise a probe combined with each primer described herein.

[0012] In another aspect, the present invention also provides a method for simultaneous detection of pathogenic and non-pathogenic NDV in poultry using a combination of primer sets according to the present invention, the method comprising the steps of: providing a poultry sample suspected of being infected or contaminated with NDV; providing a combination of primer sets according to the present invention; performing rRT-PCR using the sample and the combination of primer sets; determining whether a nucleic acid amplification reaction by PCR of each of the NDV common primer set and the pathogenic primer set occurs during or after the nucleic acid amplification reaction; and determining, as a result of the determination, that if nucleic acid amplification occurs only in the common primer set, the sample is infected with non-pathogenic NDV, and if nucleic acid amplification occurs in both the common primer set and the pathogenic NDV-specific primer set, the sample is determined to be infected with pathogenic NDV.

[0013] In one embodiment, each of the above primer sets is used together with a probe, and the first primer set, the second primer set, the third primer set, and the fourth primer set further comprise probes of SEQ ID NO: 3, SEQ ID NO: 6, SEQ ID NO: 9, and SEQ ID NO: 12, respectively, and the fifth primer set, the sixth primer set, and the seventh primer set further comprise probes of SEQ ID NO: 15 or SEQ ID NO: 18, respectively. In this case, the probes used together with the common and pathogenic primers are labeled with fluorescent substances of different wavelengths, so that it is easy to determine whether nucleic acid amplification by PCR reaction occurs, and thus it is possible to determine whether infection with non-pathogenic or pathogenic NDV occurs.

[0014] The poultry samples used in the method according to the present invention include poultry or bird pathogen test samples including chickens, ducks, pheasants, ostriches, geese, turkeys, quails or pigeons; slaughter products thereof; broilers, laying hens, breeding hens thereof; samples derived from these farms; SPF (Specific Pathogen Free) poultry or their eggs or samples derived from these farms.

[0015] The primer set according to the present invention can rapidly detect the presence of NDV pathogen contamination in various specimens, including veterinary pathogen identification samples, with high specificity and sensitivity. In addition, it can be widely used for disease monitoring in poultry farms by differentiating NDV and pathogenic (intermediate and virulent) NDV and measuring the titer. In particular, it has the advantage of reducing the time and increasing the convenience of use for vaccine manufacturers by accurately measuring the titer of the virus through real-time polymerase chain reaction and utilizing it in vaccine manufacturing. In addition, it can be effectively used as a genetic detection method for specifically detecting NDV and pathogenic (intermediate and virulent) NDV.

[0016] Figures 1a and 1b are the results of detecting the specificity and sensitivity of NDV-specific primer set 1 for the combination of Table 2 with the primers described in Table 1 according to one implementation example of the present invention.

[0017] Figures 2a and 2b are the results of detecting the specificity and sensitivity of NDV-specific primer set 2 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0018] Figures 3a and 3b show the results of detecting the specificity and sensitivity of NDV-specific primer set 3 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0019] Figures 4a and 4b show the results of detecting the specificity and sensitivity of NDV-specific primer set 5 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0020] Figures 5a and 5b show the results of detecting the specificity and sensitivity of NDV-specific primer set 9 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0021] Figures 6a and 6b show the results of detecting the specificity and sensitivity of NDV-specific primer set 10 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0022] Figures 7a and 7b show the results of detecting the specificity and sensitivity of NDV-specific primer set 11 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0023] Figures 8a and 8b show the results of detecting the specificity and sensitivity of NDV-specific primer set 12 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0024] Figures 9a and 9b show the results of detecting the specificity and sensitivity of NDV-specific primer set 16 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0025] Figures 10a and 10b show the results of detecting the specificity and sensitivity of NDV-specific primer set 17 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0026] Figures 11a and 11b show the results of detecting the specificity and sensitivity of NDV-specific primer set 18 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0027] Figures 12a and 12b show the results of detecting the specificity and sensitivity of NDV-specific primer set 19 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0028] Figures 13a and 13b show the results of detecting the specificity and sensitivity of NDV-specific primer set 20 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0029] Figure 14 shows the results of detecting the sensitivity of rRT-PCR according to the viral titer of NDV-specific primer set 1 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0030] Figure 15 shows the results of detecting the sensitivity of rRT-PCR according to the viral titer of NDV-specific primer set 2 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0031] Figure 16 shows the results of detecting the sensitivity of rRT-PCR according to the viral titer of NDV-specific primer set 3 for the combination of Table 2 with the primers described in Table 1 according to another implementation example of the present invention.

[0032] The present invention relates to a primer set capable of specifically detecting NDV using the rRT-PCR method and a method for detecting, differentiating and quantifying NDV and pathogenic (intermediate-virulent and strong-virulent) NDV using the same.

[0033] This invention is based on the discovery that NDV and pathogenic (intermediate and highly virulent) NDV can be easily detected and differentiated at the nucleic acid level with high accuracy and sensitivity using the rRT-PCR method. The invention relates to a primer set that can specifically detect NDV and a method for differentiating, quantifying and / or detecting pathogenic (intermediate and highly virulent) and non-pathogenic NDV using the same.

[0034] NDV belongs to the genus Avulavirus of the family Paramyxoviridae, and can infect most birds, including chickens, pheasants, ostriches, pigeons, quail, turkeys, and geese. NDV is classified into velogenic, mesogenic, lentogenic, and apathogenic types according to the virulence of the virus according to the World Odds-Of-Avoidance (WOAH). In WOAH, infection by NDV of the mesogenic type or higher is considered as the occurrence of Newcastle disease, and infection causes respiratory, digestive, and neurological symptoms. When infected with the mesogenic type, weight loss or reduced egg production occurs, and death may occur in young chicks. When infected with the apathogenic type, green diarrhea and reduced egg production along with neurological symptoms appear, and the mortality rate can be almost 100%.

[0035] In this application, poultry includes domesticated birds or birds including chickens, ducks, pheasants, ostriches, geese, turkeys, quails or pigeons.

[0036] In one aspect, the present invention relates to a primer set for rRT-PCR analysis specific for NDV, and relates to the primer set and / or probe of Table 1 below. NDV common type means a primer capable of detecting both non-pathogenic and pathogenic NDV, and pathogenic specific (patho-type) means a primer capable of specifically detecting only pathogenic NDV.

[0037] In one embodiment, the NDV common primer set is a first primer set of SEQ ID NO: 1 and SEQ ID NO: 2; a second primer set of SEQ ID NO: 4 and SEQ ID NO: 5; a third primer set of SEQ ID NO: 7 and SEQ ID NO: 8; or a fourth primer set of SEQ ID NO: 10 and SEQ ID NO: 11.

[0038] In another embodiment, the pathogenic NDV-specific primer set is a fifth primer set of SEQ ID NO: 13 and SEQ ID NO: 14; a sixth primer set of SEQ ID NO: 13 and SEQ ID NO: 16; or a seventh primer set of SEQ ID NO: 13 and SEQ ID NO: 17.

[0039] In another aspect, the present invention relates to a combination of NDV common and pathogenic NDV specific primer sets of Table 1 according to the present invention.

[0040] When these two primer sets are used in combination, infection with pathogenic and / or nonpathogenic NDV can be detected in a single PCR reaction. Specifically, amplification from both the common and pathogenic primers indicates pathogenic NDV, whereas amplification only with the common primer indicates infection with nonpathogenic NDV.

[0041] In one embodiment, the combination of primer sets for simultaneous detection is any one combination selected from the group consisting of a first primer set and a fifth primer set; a first primer set and a sixth primer set; a first primer set and a seventh primer set; a second primer set and a fifth primer set; a second primer set and a sixth primer set; a second primer set and a seventh primer set; a third primer set and a fifth primer set; a third primer set and a sixth primer set; a third primer set and a seventh primer set; a fourth primer set and a fifth primer set; a fourth primer set and a sixth primer set; and a fourth primer set and a seventh primer set.

[0042] [Table 1]

[0043]

[0044]

[0045] HEX, TAMRA, FAM, and Black Quencher1, which are listed at 5' and 3' of the probe sequence in Table 1 above, are dyes used for real-time nucleic acid amplification, and these dyes can be purchased commercially.

[0046] In one embodiment, any one of the primer sets or combination of primer sets and probes according to the present invention is used in PCR.

[0047] In this paper, PCR (Polymerase Chain Reaction) is a method widely known in the art that uses a polymerase to synthesize nucleic acids in a chain to exponentially amplify the starting nucleic acid material, and it is a concept that includes qualitative analysis PCR that confirms the presence or absence of a specific nucleic acid, quantitative PCR that measures the amount of a specific nucleic acid, and real-time PCR that enables qualitative and quantitative analysis by tracking the PCR process in real time. RT (Reverse Transcription) refers to reverse transcription, and it is a process of synthesizing cDNA, which serves as a PCR template, from RNA in the previous step of PCR. In this paper, RT and PCR are performed in a single tube.

[0048] In this study, real-time PCR is a method that can track the process in real time, and the values ​​used for qualitative or quantitative analysis are Ct or Cq. The above terms are used interchangeably, and the above terms indicate the number of PCR cycles at which the amplification curve reaches a specific threshold during the amplification process. The threshold is usually determined as the point where the curvature of the amplification curve is maximum and is located in the exponential phase. Quantitative or qualitative analysis of nucleic acids using this value can be performed according to the manual of the real-time PCR device manufacturer. In this PCR, the step of confirming whether a specific DNA is amplified can be performed by checking the size of the amplified DNA product through electrophoresis, etc. Alternatively, the above real-time polymerase chain reaction can be performed by using a fluorescent material such as commercially available SYBR Green to measure the degree of fluorescence simultaneously with amplification without an additional confirmation procedure, or by measuring fluorescence resonance energy transfer (FRET) to confirm whether amplification has occurred, and additionally, by including a step of confirming the temperature at which the double helix of the amplified DNA product separates (melting temperature), in which case a probe is used.

[0049] In addition to the primer set in real-time PCR according to the present invention, a probe is additionally used.

[0050] In this application, the term "primer" refers to a ribonucleotide or deoxyribonucleotide of any length, including both single-stranded and double-stranded ones, and is a concept that includes both primers and probes. It refers to an oligonucleotide having a sequence complementary to at least a part of a gene specific to each strain to be detected, and serves as a starting point for polymerization in a polymerization reaction using a polymerase such as polymerase chain reaction.

[0051] The principle of this invention is that the probe binds between the primer sets used together with the oligonucleotide, and the fluorescent substance released from the probe according to the PCR reaction can be detected for quantification. Accordingly, the probe can be labeled with an appropriate fluorescent substance such as Table 1 and Examples of this invention at the 5' and 3' ends.

[0052] In one implementation, the 5' end is 6-FAM as described in Table 1. TM (5'-Fluorescein phosphoramidite) or HEX TM (5'-Hexachloro Fluorescein), and the 3' end is TAMRA TM It can be labeled with a fluorescent substance such as (5'-Carboxytetramethylrhodamine) or BHQ1 (5'-BlackHole Quencher1) and used in a TaqMan reaction known to those skilled in the art.

[0053] In one embodiment according to the present invention, a primer set according to the present invention and a combination thereof are used for real-time PCR.

[0054] In one embodiment, the primer sets and probe combinations are as shown in Tables 1 and 2: Set1 (I-V); Set2 (I-V); Set3 (I-VII); Set4 (II-V); Set5 (II-V); Set6 (II-VII); Set7 (III-V); Set8 (III-V); Set9 (III-V); Set10 (IV-V); Set11 (IV-V); Set12 (II-V); Set13 (II-Ⅸ); Set14 (II-Ⅹ); Set15 (III-Ⅷ); Set16 (III-Ⅸ); Set17 (III-Ⅹ); Set18 (IV-Ⅷ); Set19 (IV-Ⅸ); Set20 (IV-Ⅹ).

[0055] [Table 2]

[0056]

[0057]

[0058] Any one primer set or primer set and probe according to the present invention can detect NDV with high specificity and sensitivity.

[0059] Any one of the primer sets and probes according to the present invention can detect pathogenic (intermediate and strong virulent) NDV with high specificity and sensitivity.

[0060] Any one primer set and probe according to the present invention can simultaneously detect NDV and pathogenic (intermediate and strong virulent) NDV with high specificity and sensitivity.

[0061] In this application, detection means detecting the presence or absence of nucleic acid or, if present, the amount thereof, and can be achieved by using a method based on a nucleic acid-specific DNA-DNA, RNA-DNA hybridization reaction, for example, PCR (including quantitative analysis for titer measurement and qualitative analysis for infection detection PCR, real-time quantitative or qualitative PCR).

[0062] The primer set and the primer set and the probe according to the present invention can specifically and simultaneously detect NDV and pathogenic (intermediate and virulent) NDV in poultry samples infected with or suspected of being infected with NDV and pathogenic (intermediate and virulent) NDV.

[0063] The primer set according to this invention is used for various samples that require NDV detection and pathogenicity differentiation. Since NDV causes systemic infection, it can be isolated from most organs, but it is mainly used, but not limited to, the trachea, intestines, glands, or cecum.

[0064] In this study, poultry samples include samples for pathogen identification; slaughter products thereof; broilers, laying hens, and breeding hens thereof; samples derived from their farms; SPF (Specific Pathogen Free) poultry or their eggs or samples derived from their farms.

[0065] The method according to the present invention can be used for qualitative or quantitative analysis.

[0066] In one implementation example, it is used for qualitative analysis and can be used to determine whether a sample is infected with NDV.

[0067] In another embodiment, it is used for quantitative analysis and can be used to determine the titer of NDV infected in a sample. Existing NDV quantification requires culturing the virus in cells or eggs, which takes a lot of time, more than 5 days, and requires skilled researchers who can skillfully cultivate cells or eggs without contamination. In addition, when culturing in eggs, there is a disadvantage in that eggs must be imported from abroad. On the other hand, when using this primer set, the quantification of NDV can be confirmed quickly, so it can be applied to vaccine manufacturing, etc. The above analysis is a quantitative analysis, and in one embodiment, the titer measurement method is to add a known EID (Egg Infectious Dose) to the avian-derived sample in the amplification reaction step. 50 A step of performing a nucleic acid amplification reaction on a standard sample containing NDV to create a standard curve; and a step of analyzing the amplification reaction result, and a step of comparing the nucleic acid amplification reaction analysis result on the standard sample with the nucleic acid amplification reaction analysis result on the sample derived from birds to determine the amount of NDV infected in the sample derived from birds.

[0068] In this respect, the present invention relates to a composition or kit for diagnosing or detecting NDV and pathogenic (intermediate and strong toxigenic) NDV, comprising at least one of the primer sets of Table 1 or a combination thereof and a probe.

[0069] In one embodiment, the composition comprises a buffer, Taq polymerase, and MgCl2 required for a PCR reaction. Various buffers known in the art can be used, including, but not limited to, Tris-HCl, pH 9.0 buffer. Taq polymerase is commercially available, such as AmpliTaq Gold (Applied Biosystems, USA), and may include an appropriate concentration of MgCl2, such as 1.5 mM to 2.5 mM.

[0070] In one embodiment, the kit further comprises a positive control, a negative control, and instructions for use. The negative control may use RNA or DNA of a virus other than the target virus, and for example, the positive control may use a plasmid containing the genes of the target virus.

[0071] The present invention relates to a method for detecting / differentiating NDV, comprising the step of performing nucleic acid amplification by mixing one or more of the primer sets of Table 1 or a combination thereof with a probe with a sample or environmental sample derived from avian species, including poultry, requiring quantitative / diagnosis of NDV and pathogenic (intermediate and virulent) NDV.

[0072] In one embodiment, a method for simultaneous detection of pathogenic and non-pathogenic NDV in poultry using a combination of primer sets of the present disclosure comprises the steps of: providing a poultry sample suspected of being infected or contaminated with NDV; providing a combination of primer sets according to the present disclosure; performing rRT-PCR using the combination of the sample and the primer sets; determining a PCR reaction result of each of the NDV common primer set and the pathogenic primer set during or after the PCR reaction, for example, whether the PCR reaction is negative or positive; and determining that, if a PCR reaction occurs only in the common primer set, the sample is infected with non-pathogenic NDV, and if a PCR reaction occurs in both the common primer and the pathogenic NDV-specific primer set, the sample is infected with pathogenic NDV.

[0073] In this study, real-time PCR is used, and in real-time PCR, common and pathogenic probes are labeled with fluorescent substances of different wavelengths, so that the PCR result can be determined in a way that the positive or negative result of the PCR reaction and, if positive, the quantification can be performed simultaneously.

[0074] For example, in one implementation, the method according to the present invention is performed by TaqMan-based real-time polymerase chain reaction (real-time PCR), and the reaction volume is 20 μl in total, including BlackPCR RT-qPCR (Ventech Science, South Korea) with an NDV-specific primer set and 2.0 to 6.0 μl of the sample to be analyzed.

[0075] In other implementations, the PCR reaction results can be analyzed by performing an agarose gel analysis to determine differences in the size of the PCR results and / or by sequencing the PCR results.

[0076] In one embodiment, the combination of primer sets according to the present invention is such that reverse transcription and PCR of the reverse transcription product are performed in a single reaction using RNA as a template. In this case, reverse transcription can be performed by adding a known primer for reverse transcription, or can be performed using a commercially available RT-PCR kit.

[0077] In addition, the present invention can provide a method for treating pathogenic NDV in poultry, comprising the following steps:

[0078] (a) providing a sample isolated from a poultry individual suspected of being infected or contaminated with NDV;

[0079] (b) a step of performing rRT-PCR on a combination of the primer sets of the present invention described above in the sample of step (a) to detect the presence of pathogenic NDV;

[0080] (c) a step of diagnosing an individual as being infected with a pathogenic NDV if a pathogenic NDV is present in the sample in step (b); (d) a step of administering an effective amount of a therapeutic agent to an individual diagnosed as being infected with a pathogenic NDV in step (c).

[0081] That is, by using a combination of primer sets according to the present invention, pathogenic NDV is detected at the nucleic acid level, and compared with a control group or reference group, if a person is diagnosed as infected with pathogenic NDV based on the presence or absence of nucleic acid, increase in nucleic acid, or degree of change, the person is judged to be in need of treatment, and the treatment is administered, thereby blocking the spread of pathogenic NDV and enabling appropriate treatment.

[0082] Any therapeutic agent known in the art can be used as the therapeutic agent as long as it can achieve the purpose of the present invention, and includes one that induces NDV killing and / or reduces NDV viability.

[0083]

[0084] The present invention is described in detail through the following examples, but these examples are merely illustrative and do not limit the scope of the present invention in any way.

[0085] Unless otherwise specified, the present invention can be practiced using conventional techniques within the skill of those skilled in the art in cell biology, cell culture, molecular biology, genetic transformation technology, microbiology, and DNA recombinant technology. For more detailed descriptions of general techniques, see Molecular Biotechnology: (Bernard et al., ASM press 2014); Molecular Cloning: A Laboratory Manual, 4th Ed. (Sambrook et al., Cold Spring Harbor Laboratory Press 2012); and Short Protocols in Molecular Biology, 5th Ed. (Ausubel F. et al. eds., John Wiley & Sons 2002).

[0086]

[0087] Example 1. Preparation of Newcastle disease virus samples

[0088] NDV Kr005, Kr / KJW / 49, Kr / 48 / 82, Hert33 / 56, UPM 111, which were confirmed to be virulent in our hospital, and Lasota and VG / GA, which are known to be weakly virulent, were inoculated into the allantoic cavity of 9-day-old SPF hatching eggs and cultured in an incubator at 37℃ for approximately 5 days. After collecting the allantoic fluid, RNA was prepared using the QIAamp RNA Mini kit (Qiagen, Germany) according to the manufacturer's instructions.

[0089] Example 2. Production of Newcastle disease virus-specific primers

[0090] To accurately and simultaneously detect NDV and pathogenic (intermediate and highly virulent) NDV, various genes were obtained from NCBI and GenBank and virus-specific final primers were selected. Specifically, the F and HN proteins present in the NDV envelope play a crucial role in the pathogenesis and immune defense mechanisms. F facilitates viral infection by inducing fusion with the cell membrane before cell invasion and allowing the nucleocapsid and its accessory proteins to enter the host cell. In addition, F0 synthesized during viral replication is cleaved into F1 and F2 by intracellular enzymes, and this cleavage activation is related to NDV pathogenicity. In the existing literature, if consecutive basic amino acids from amino acids 112 to 116 in the F segment and phenylalanine (F) are present at amino acid 117, it is determined to be intermediately virulent or more pathogenic NDV. Otherwise, it is determined to be non-pathogenic (attenuated or avirulent) NDV. HN functions to help the virus easily invade the host cell by attaching the virus to the sialic acid-containing receptor present on the host cell surface. The M gene is known to play an important role in virus assembly. Therefore, based on F (GenBank accession numbers, KF724899, A03663, MF581298, and AF456442), HN (GenBank accession numbers, A03663, KF783008, JN682207, and EU183408), and M (GenBank accession numbers, M16622, FJ772482, AY728363, and JN682198), we constructed specific primers and completed a primer set for rRT-PCR amplification (Table 1). The base sequences of each primer are available from NCBI (National Center for Biotechnology Information), Genbank, and Blast (http: / blast.ncbi.As a result of verification using the nlm.nih.gov / Blast.cgi website, no matching base sequences other than the virus in question existed.

[0091] Example 3. Confirmation of the specificity and sensitivity of rRT-PCR reaction using primers according to the present invention.

[0092] First, the specificity was confirmed through cross-reaction between NDV, including virulent and attenuated forms, using the primer sets in Table 1. In addition, the specificity of the reactants was confirmed through cross-reaction between avian paramyxovirus-2, -3, -4, -6, -7, -8, -9 serotypes (APMV-2, -3, -4, -6, -7, -8, -9), avian influenza A(H9N2) virus, avian encephalomyelitis virus (AEV), infectious bursal disease virus (IBDV), and infectious bronchitis virus (IBV) using rRT-PCR (Table 3).

[0093] For this purpose, the genome obtained in Example 1 was prepared at 100 ng / ul. Then, BlackPCR RT-qPCR (Ventech Science, South Korea) was used, and a solution containing 0.25 uM of each Common-type-specific forward, reverse, and probe primer, 0.5 uM of each Patho-type-specific forward and reverse primer, 0.25 uM of Patho-type-specific probe primer, and 3 μl of the above-mentioned isolated RNA was used in a total volume of 20 μl.

[0094] The steps of synthesizing cDNA at 50°C for 10 minutes, heating at 95°C for 20 seconds, denaturing at 95°C for 5 seconds, annealing at 55°C for 50 seconds, and polymerization were repeated 40 times in one cycle.

[0095] As a result, as shown in Table 3, the common-type specific primers in primer sets 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 can detect both virulent and attenuated NDVs, while the patho-type specific primers included in primer sets 1, 2, 3, 4, 5, 6, 12, 13, 14, 15, 16, 17, 18, 19 or 20 can specifically differentiate only pathogenic (intermediate-virulent and potent) NDVs.

[0096] In addition, RNA genomes were extracted from avian paramyxovirus-2, -3, -4, -6, -7, -8, -9 serotypes (APMV-2, -3, -4, -6, -7, -8, -9), avian influenza A(H9N2) virus, avian encephalomyelitis virus (AEV), infectious bursal disease virus (IBDV), and infectious bronchitis virus (IBV), and then each RNA was prepared at a concentration of 100 ng / ul and rRT-PCR was performed. For rRT-PCR analysis, BlackPCR RT-qPCR (Ventech Science, South Korea) was used. A solution containing 0.25 uM of each Common-type-specific forward, reverse, and probe primer, 0.5 uM of each Patho-type-specific forward and reverse primer, 0.25 uM of Patho-type-specific probe primer, and 3 μl of the isolated RNA in a total volume of 20 μl was used to synthesize cDNA at 50°C for 10 minutes, followed by heating at 95°C for 20 seconds, denaturation at 95°C for 5 seconds, annealing at 55°C for 50 seconds, and polymerization, which was repeated 40 times per cycle.

[0097] As a result, as shown in Table 3 and Figures 1a, 2a, 3a, 4a, 5a, 6a, 7a, 8a, 9a, 10a, 11a, 12a and 13a, it was found that it did not cross-react with other similar viruses and specifically detected only the virus in question.

[0098] [Table 3]

[0099]

[0100]

[0101] Next, the sensitivity to NDV and pathogenic (intermediate and strong virulent) NDV was confirmed using the primer sets of each combination. A step of synthesizing cDNA at 50°C for 20 minutes using the HN forward primer 5'-CAAGAACACCTGAATTTTATCCC-3' and the HN reverse primer 5'-GATAGATAAGATGGCTTGCTGTA-3', the M forward primer 5'-AACACGGGTAGAAGAGTCTGG-3' and the M reverse primer 5'-CCATATTGCCACCAGCTAGATTGTAA-3', another M forward primer 5'-CAATACAGGATCCAGCGTCTTGA-3' and the M reverse primer 5'-ATAGCAGGCTGTCCCACTG-3', the F forward primer 5'-AATATGCCCAAGGATAAAGAGGC-3' and the F reverse primer 5'-TAATGAGCTGAGTTGGTTGTTCC-3', which can amplify the HN, M, and F gene regions of NDV, and a step of heating at 94°C for 5 minutes. Amplification was performed by repeating 35 cycles of denaturation at 94°C for 50 seconds, annealing at 58°C for 50 seconds, and polymerization at 72°C for 50 seconds, followed by polymerization at 72°C for 5 minutes. The amplified products of 658 bp, 787 bp, 788 bp, and 587 bp in size were purified according to the manufacturer's method (gel extraction kt, Qiagen, Germany) and inserted into pGEM-T Easy Vector (Promega, USA), and pGEM-HN, pGEM-M-787, pGEM-M-788, and pGEM-F were constructed.

[0102] The above-mentioned constructed pGEM-HN and pGEM-F were added as one set, pGEM-M-787 and pGEM-F as another set, and pGEM-M-788 and pGEM-F as another set, respectively, in 1.0 x 10 ㎕ reaction solution. 8 copies, 1.0 x 10 7 copies, 1.0 x 10 6 copies, 1.0x 105 copies, 1.0 x 10 4 copies, 1.0 x 10 3 copies, 1.0 x 10 2 copies, 1.0 x 10 1 copies were prepared by diluting to a concentration of 10 copies. 0.25 μM of each Common-type-specific forward, reverse, and probe primer, 0.5 μM of each Patho-type-specific forward and reverse primer, and 0.25 μM of Patho-type-specific probe primer were added to BlackPCR RT-qPCR (Ventech Science, South Korea), and the final reaction mixture was adjusted to 20 μL with 2 μL of each NDV plasmid DNA and sterile distilled water, and then TaqMan probe-based nucleic acid amplification reaction was performed under the following conditions: heating at 95°C for 20 s, denaturation at 95°C for 5 s, annealing at 55°C for 50 s, and polymerization reaction, repeated 40 times per cycle.

[0103] The results are shown in Table 4 with sensitivity underlined and in Figures 1b, 2b, 3b, 4b, 5b, 6b, 7b, 8b, 9b, 10b, 11b, 12b and 13b.

[0104] In addition, standard regression analysis was performed between Ct values ​​(y-axis) for pGEM-HN, pGEM-M-787, pGEM-M-788, and pGEM-F log titer (x-axis). As a result, the regression equation of TaqMan probe-based real-time polymerase chain reaction was as follows: Common-type was R when using Set 1 primers in Table 2 2 = 0.998, efficiency = 100.2%, Patho-type is R 2 = 0.998, efficiency = 104.7%, when using Set 2 primers, Common-type is R 2= 0.997, efficiency = 96.8%, Patho-type is R 2 = 0.997, efficiency = 101.2%, when using Set 3 primers, Common-type is R 2 = 0.999, efficiency = 95.1%, Patho-type is R 2 = 0.997, efficiency = 92.6%, when using Set 5 primers, Common-type is R 2 = 0.997, efficiency = 99.7%, Patho-type is R 2 = 0.987, efficiency = 97.1%, when using Set 9 primers, Common-type is R 2 = 0.993, efficiency = 96.9%, Patho-type is R 2 = 0.991, efficiency = 100.9%, when using Set 10 primers, Common-type is R 2 = 0.997, efficiency = 99.1%, Patho-type is R 2 = 0.994, efficiency = 94.3%, when using Set 11 primers, Common-type is R 2 = 0.997, efficiency = 98.1%, Patho-type is R 2 = 0.997, efficiency = 95.9%, when using Set 12 primers, Common-type is R 2 = 0.995, efficiency = 99.5%, Patho-type is R 2 = 0.997, efficiency = 90.1%, when using Set 16 primers, Common-type is R 2 = 0.990, efficiency = 91.1%, Patho-type is R 2= 0.988, efficiency = 97.9%, when using Set 17 primers, Common-type is R 2 = 0.992, efficiency = 90.9%, Patho-type is R 2 = 0.987, efficiency = 90.6%, when using Set 18 primers, Common-type is R 2 = 0.988, efficiency = 93.5%, Patho-type is R 2 = 0.982, efficiency = 102.8%, when using Set 19 primers, Common-type is R 2 = 0.996, efficiency = 91.2%, Patho-type is R 2 = 0.983, efficiency = 104.9%, when using Set 20 primers, Common-type is R 2 = 0.988, efficiency = 98.0%, Patho-type is R 2 = 0.986, efficiency = 103.3% was obtained.

[0105] This indicates that the regression between NDV log titer and Ct values ​​is very good, indicating that virus titration analysis using primer sets 1, 2, 3, 5, 9, 10, 11, 12, 16, 17, 18, 19, and 20 is possible.

[0106] [Table 4]

[0107]

[0108]

[0109] And the strong-type Kr005 was inoculated into the allantoic cavity of 9-day-old SPF hatching eggs and cultured in an incubator at 37℃ for about 5 days. Then, the chicken hemagglutination (HA) was examined to measure the virus proliferation titer. The virus titer was calculated as the reciprocal of the virus dilution that can infect 50% of the inoculated eggs, i.e., the 50% egg infectious dose (EID 50 ) were expressed as , and RNA was extracted from allantoic cavity fluid collected aseptically. Using the prepared RNA, the sensitivity was confirmed under the same composition and reaction conditions with primer sets 1, 2, and 3 in Table 2. The experimental results are shown in Figures 14, 15, and 16, and Set 1 was 1.0 x 10 2 EID 50 / ㎖ or higher concentration, Set 2 and 3 are 1.0 x 10 3 EID 50 It was confirmed that it can be detected within about 1 hour at a concentration of / ㎖ or more, and through this, it was found that NDV and pathogenic (intermediate and strong virulence) NDV can be detected and quantified quickly and accurately with a shorter reaction time than RT-PCR-based nucleic acid amplification reaction that takes more than 2 hours.

[0110] Example 4. Detection of nonpathogenic and pathogenic Newcastle disease virus in chickens in rRT-PCR reaction using primers according to the present invention.

[0111] Using the established rRT-PCR method, we artificially inoculated SPF chickens with virulent NDV and conducted a virus detection test. The titer in 4-week-old chickens was 10 6.0 EID 50 RNA was extracted from trachea and cecal tonsil samples obtained 3 days after infection with 0.1 ml of the toxic NDV, and rRT-PCR was performed using the primer set in Table 1.

[0112] As a result, as shown in Table 5, when using the primer set of the present invention, simultaneous detection (simultaneous diagnosis) of non-pathogenic and pathogenic Newcastle disease viruses of the target is possible through a single gene amplification.

[0113] [Table 5]

[0114]

Claims

1. A combination of NDV common and pathogenic NDV-specific primer sets for rRT (real-time reverse transcription)-PCR (Polymerase Chain Reaction) analysis for simultaneous detection of pathogenic and non-pathogenic NDV (Newcastle Disease Virus) in poultry. The above NDV common primer set is: a first primer set of SEQ ID NO: 1 and SEQ ID NO: 2; a second primer set of SEQ ID NO: 4 and SEQ ID NO: 5; a third primer set of SEQ ID NO: 7 and SEQ ID NO: 8; or a fourth primer set of SEQ ID NO: 10 and SEQ ID NO: 11; The above pathogenic NDV-specific primer set is: a fifth primer set of SEQ ID NO: 13 and SEQ ID NO: 14; a sixth primer set of SEQ ID NO: 13 and SEQ ID NO: 16; or a seventh primer set of SEQ ID NO: 13 and SEQ ID NO: 17; The combination of primer sets for the above simultaneous detection is: Any one combination selected from the group consisting of combinations of the first primer set and the fifth primer set; the first primer set and the sixth primer set; the first primer set and the seventh primer set; the second primer set and the fifth primer set; the second primer set and the sixth primer set; the second primer set and the seventh primer set; the third primer set and the fifth primer set; the third primer set and the sixth primer set; the third primer set and the seventh primer set; the fourth primer set and the fifth primer set; the fourth primer set and the sixth primer set; and the fourth primer set and the seventh primer set. Combination of NDV common and pathogenic NDV-specific primer sets for rRT-PCR analysis.

2. In paragraph 1, The first primer set, the second primer set, the third primer set and the fourth primer set further include probes of SEQ ID NO: 3, SEQ ID NO: 6, SEQ ID NO: 9 and SEQ ID NO: 12, respectively. The fifth primer set, the sixth primer set and the seventh primer set each additionally include a probe of SEQ ID NO: 15 or SEQ ID NO:

18. Combination of NDV common and pathogenic NDV-specific primer sets for rRT-PCR analysis.

3. In paragraph 2, Each of the above probes is labeled with a detectable labeling substance, Combination of NDV common and pathogenic NDV-specific primer sets for rRT-PCR analysis.

4. A composition for rRT-PCR analysis for simultaneous detection of pathogenic and non-pathogenic NDV in poultry, comprising a combination of NDV common and pathogenic NDV specific primer sets for rRT-PCR analysis according to any one of claims 1 to 3.

5. An rRT-PCR analysis kit for simultaneous detection of pathogenic and non-pathogenic NDV in poultry, comprising a combination of NDV common and pathogenic NDV specific primer sets for rRT-PCR analysis according to any one of claims 1 to 3.

6. A method for simultaneous detection of pathogenic and non-pathogenic NDV in poultry, comprising the following steps: (a) providing a sample isolated from poultry suspected of being infected or contaminated with NDV; (b) providing a combination of primer sets according to paragraph 1; (c) performing rRT-PCR using the combination of the above sample and primer set; and (d) a step of determining whether the nucleic acid amplification reaction of each of the NDV common primer set and the pathogenic primer set occurred during or after the nucleic acid amplification reaction of the rRT-PCR, wherein if the nucleic acid amplification occurred only by the common primer set, the sample is determined to be infected with non-pathogenic NDV, and if the nucleic acid amplification occurred by both the common primer and the pathogenic NDV-specific primer set, the sample is determined to be infected with pathogenic NDV. A method for simultaneous detection of pathogenic and non-pathogenic NDV in poultry.

7. In paragraph 6, In the step of performing the above (c) rRT-PCR The first primer set, the second primer set, the third primer set and the fourth primer set further include probes of SEQ ID NO: 3, SEQ ID NO: 6, SEQ ID NO: 9 and SEQ ID NO: 12, respectively. The fifth primer set, the sixth primer set and the seventh primer set each additionally include a probe of SEQ ID NO: 15 or SEQ ID NO:

18. A method for simultaneous detection of pathogenic and non-pathogenic NDV in poultry.

8. In paragraph 6, The above poultry includes a pathogen test sample of poultry or birds including chicken, duck, pheasant, ostrich, goose, turkey, quail or pigeon; slaughter products thereof; broilers, laying hens, breeding hens thereof; samples derived from these farms; SPF (Specific Pathogen Free) poultry or their eggs or samples derived from these farms. A method for simultaneous detection of pathogenic and non-pathogenic NDV in poultry.

9. A method for treating pathogenic NDV in poultry, comprising the following steps: (a) providing a sample isolated from a poultry individual suspected of being infected or contaminated with NDV; (b) a step of performing rRT-PCR on a sample of step (a) using a combination of primer sets according to paragraph 1 to detect the presence of pathogenic NDV; (c) a step of diagnosing an individual as being infected with a pathogenic NDV if a pathogenic NDV is present in the sample in step (b); (d) a step of administering an effective amount of a therapeutic agent to an individual diagnosed as being infected with a pathogenic NDV in step (c).